Get started
Author

E. Testa

Observed names: E Testa, TESTA E, Testa E
OpenAlex ID: A5113670524
Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients
2002 · F Graziano, R Bisonni, et al. · British Journal of Cancer · 108
PDF
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer.
1997 · S Cascinu, R Labianca, et al. · Journal of Clinical Oncology · 103
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
2008 · V Catalano, F Graziano, et al. · British Journal of Cancer · 101
PDF
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
2007 · A Ruzzo, F Graziano, et al. · The Pharmacogenomics Journal · 100
A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer
2000 · F. Graziano, V. Catalano, et al. · Annals of Oncology · 85
Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype
2005 · A. Ruzzo, F. Graziano, et al. · Annals of Oncology · 71
PDF
Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs
2004 · F. Graziano, F. Arduini, et al. · Annals of Oncology · 54
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial
2006 · D Santini, F Graziano, et al. · BMC Cancer · 34
PDF
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer
2003 · F Graziano, D Santini, et al. · British Journal of Cancer · 26
PDF
An endogastric capsule for measuring tumor markers ingastric juice: an evaluation of the safety and efficacy of a new diagnostic tool
2002 · P. Muretto, F. Graziano, et al. · Annals of Oncology · 24
PDF
Over-D1 dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients
2005 · M Scartozzi, E Galizia, et al. · British Journal of Cancer · 15
PDF
Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicentre phase II trial.
2004 · R Mattioli, P Lippe, et al. · PubMed · 13
MO01.02 Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab in the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the United States
2021 · M. Berling, M.A. Chaudhary, et al. · Journal of Thoracic Oncology · 10
Weekly oxaliplatin, fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer (AGC)
2004 · D. Santini, F. Graziano, et al. · Journal of Clinical Oncology · 3
Soy Intake and Breast Cancer
2018 · Virgili E, Calza L, et al. · Journal of Health & Medical Informatics · 1
KRAS has a role in acquired resistance to EGFR-TKIs in NSCLC: an analysis on circulating tumor DNA
2015 · M. Del Re, M. Tiseo, et al. · Annals of Oncology · 1
PDF
Liquid Biopsy to Monitor the Evolution of Nsclc Egfr+During Treatment with Gefintinib
2014 · D. Spada, M. Del Re, et al. · Annals of Oncology · 1
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors (PNETs)
2016 · R. Berardi, S. Pusceddu, et al. · Annals of Oncology
Prognostic factors for patients with advanced gastric cancer receiving irinotecan, 5-fluorouracil (5-FU), and leucovorin (FOLFIRI) as salvage therapy after fluoropyrimidine/platinum-based chemotherapy: A retrospective analysis
2011 · Catalano, Daniele Santini, et al. · CINECA IRIS Institutial research information system (University of Pisa)
Folfiri as salvage therapy after fluoropyrimidine and platinum-based first-line chemotherapy for advanced gastric cancer: multivariate analysis of prognostic factors
2011 · Paolo Giordani, Catalano, et al. · Tumori
Host genetic variants in the Insulin Growth Factor Binding Protein-3 impact on servival of patients with advanced gastric cancer treated with palliative chemotharapy
2010 · Francesco Graziano, Annamaria Ruzzo, et al. · CINECA IRIS Institutial research information system (University of Pisa)
Predictive role of a pharmacogenetic profiling in patients with advanced colorectal cancer (ACRC) treated with first-line, 5-fluorouracil/oxaliplatin chemotherapy
2006 · Francesco Graziano, Antonio Russo, et al. · CINECA IRIS Institutial research information system (University of Pisa)
Predictive and prognostic role of E-cadherin expression in patients with advanced gastric cancer treated with palliative chemotherapy
2004 · F. Graziano, F. Arduini, et al. · Journal of Clinical Oncology
201 Analysis of G/A SNP change at position 2494 in the E-cadherin gene in Italian patients with sporadic, diffuse gastric cancer
2003 · A. Ruzzo, F. Graziano, et al. · European Journal of Cancer Supplements
210 An analysis of CDH1 −160 C/A promoter polymorphism and the risk of diffuse gastric cancer in Italy
2003 · A. Ruzzo, C. Spino, et al. · European Journal of Cancer Supplements
Works count: 27
Citation count: 750
H-index: 12
I10-index: 13
Year
Topic
Type